<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0173194</article-id>
<article-id pub-id-type="publisher-id">PONE-D-16-31421</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and neoplasms</subject><subj-group><subject>Head and neck cancers</subject><subj-group><subject>Head and neck tumors</subject><subj-group><subject>Head and neck squamous cell carcinoma</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and neoplasms</subject><subj-group><subject>Carcinomas</subject><subj-group><subject>Squamous cell carcinomas</subject><subj-group><subject>Head and neck squamous cell carcinoma</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Mathematical and statistical techniques</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics (mathematics)</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Chromosome biology</subject><subj-group><subject>Chromatin</subject><subj-group><subject>Chromatin modification</subject><subj-group><subject>DNA methylation</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Epigenetics</subject><subj-group><subject>Chromatin</subject><subj-group><subject>Chromatin modification</subject><subj-group><subject>DNA methylation</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Gene expression</subject><subj-group><subject>Chromatin</subject><subj-group><subject>Chromatin modification</subject><subj-group><subject>DNA methylation</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>DNA</subject><subj-group><subject>DNA modification</subject><subj-group><subject>DNA methylation</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Nucleic acids</subject><subj-group><subject>DNA</subject><subj-group><subject>DNA modification</subject><subj-group><subject>DNA methylation</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Epigenetics</subject><subj-group><subject>DNA modification</subject><subj-group><subject>DNA methylation</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Gene expression</subject><subj-group><subject>DNA modification</subject><subj-group><subject>DNA methylation</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cell processes</subject><subj-group><subject>Cell death</subject><subj-group><subject>Apoptosis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Gene types</subject><subj-group><subject>Suppressor genes</subject><subj-group><subject>Tumor suppressor genes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Lymphatic system</subject><subj-group><subject>Lymph nodes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Lymphatic system</subject><subj-group><subject>Lymph nodes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical compounds</subject><subj-group><subject>Organic compounds</subject><subj-group><subject>Alcohols</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Organic chemistry</subject><subj-group><subject>Organic compounds</subject><subj-group><subject>Alcohols</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body fluids</subject><subj-group><subject>Saliva</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body fluids</subject><subj-group><subject>Saliva</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body fluids</subject><subj-group><subject>Saliva</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body fluids</subject><subj-group><subject>Saliva</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Association between promoter methylation of <italic>DAPK</italic> gene and HNSCC: A meta-analysis</article-title>
<alt-title alt-title-type="running-head"><italic>DAPK</italic> promoter methylation and HNSCC</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Cai</surname>
<given-names>Fucheng</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Xiao</surname>
<given-names>Xiyue</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Niu</surname>
<given-names>Xun</given-names>
</name>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Zhong</surname>
<given-names>Yi</given-names>
</name>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Department of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Langevin</surname>
<given-names>Scott M.</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of Cincinnati College of Medicine, UNITED STATES</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con">
<p><list list-type="simple"> <list-item><p><bold>Conceptualization:</bold> YZ FCC.</p></list-item> <list-item><p><bold>Data curation:</bold> XYX FCC YZ.</p></list-item> <list-item><p><bold>Formal analysis:</bold> XN.</p></list-item> <list-item><p><bold>Funding acquisition:</bold> YZ.</p></list-item> <list-item><p><bold>Investigation:</bold> XYX FCC YZ.</p></list-item> <list-item><p><bold>Methodology:</bold> XYX FCC YZ.</p></list-item> <list-item><p><bold>Project administration:</bold> YZ.</p></list-item> <list-item><p><bold>Resources:</bold> XN.</p></list-item> <list-item><p><bold>Software:</bold> XYX XN.</p></list-item> <list-item><p><bold>Supervision:</bold> FCC YZ.</p></list-item> <list-item><p><bold>Validation:</bold> XYX YZ.</p></list-item> <list-item><p><bold>Visualization:</bold> YZ.</p></list-item> <list-item><p><bold>Writing – original draft:</bold> YZ FCC.</p></list-item> <list-item><p><bold>Writing – review &amp; editing:</bold> YZ.</p></list-item></list>
</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">zyzy0411@163.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>1</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>12</volume>
<issue>3</issue>
<elocation-id>e0173194</elocation-id>
<history>
<date date-type="received">
<day>5</day>
<month>8</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>2</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-year>2017</copyright-year>
<copyright-holder>Cai et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0173194"/>
<abstract>
<sec id="sec001">
<title>Background</title>
<p>The death-associated protein kinase (<italic>DAPK</italic>) is a tumor suppressor gene, which is a mediator of cell death of INF-γ–induced apoptosis. Aberrant methylation of <italic>DAPK</italic> promoter has been reported in patients with head and neck squamous cell carcinoma (HNSCC). However, the results of these studies are inconsistent. Hence, the present study aimed to evaluate the association between the promoter methylation of <italic>DAPK</italic> gene and HNSCC.</p>
</sec>
<sec id="sec002">
<title>Methods</title>
<p>Relevant studies were systematically searched in PubMed, Web of Science, Ovid, and Embase. The association between <italic>DAPK</italic> promoter methylation and HNSCC was assessed by odds ratio (ORs) and 95% confidence intervals (CI). To evaluate the potential sources of heterogeneity, we conducted the meta-regression analysis and subgroup analysis.</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>Eighteen studies were finally included in the meta-analysis. The frequency of <italic>DAPK</italic> promoter methylation in patients with HNSCC was 4.09-fold higher than the non-cancerous controls (OR = 3.96, 95%CI = 2.26–6.95). A significant association between <italic>DAPK</italic> promoter methylation and HNSCC was found among the Asian region and the Non-Asia region (Asian region, OR = 4.43, 95% CI = 2.29–8.58; Non-Asia region, OR = 3.39, 95% CI = 1.18–9.78). In the control source, the significant association between <italic>DAPK</italic> promoter methylation and HNSCC was seen among the autologous group and the heterogeneous group (autologous group, OR = 2.71, 95% CI = 1.49–4.93; heterogeneous group, OR = 9.50, 95% CI = 2.98–30.27). <italic>DAPK</italic> promoter methylation was significantly correlated with alcohol status (OR = 1.85, 95% CI = 1.07–3.21).</p>
</sec>
<sec id="sec004">
<title>Conclusion</title>
<p>The results of this meta-analysis suggested that aberrant methylation of <italic>DAPK</italic> promoter was associated with HNSCC.</p>
</sec>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution>National Nature Science Foundation of China</institution>
</funding-source>
<award-id>No. 81501297</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Cai</surname>
<given-names>Fucheng</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution>National Nature Science Foundation of China</institution>
</funding-source>
<award-id>No. 81200745</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Zhong</surname>
<given-names>Yi</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This work was supported by the National Nature Science Foundation of China (No. 81200745 and No. 81501297). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="5"/>
<table-count count="4"/>
<page-count count="13"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec005" sec-type="intro">
<title>Introduction</title>
<p>Head and neck squamous cell carcinoma(HNSCC)is the sixth most common cancer worldwide [<xref ref-type="bibr" rid="pone.0173194.ref001">1</xref>]. More than 500,000new HNSCC cases are diagnosed each year, which include two-thirds of the patients diagnosed with advanced stage, lymph node metastasis [<xref ref-type="bibr" rid="pone.0173194.ref002">2</xref>]. Moreover, the five-year survival of patients with HNSCC remains about 40–50% [<xref ref-type="bibr" rid="pone.0173194.ref002">2</xref>].The molecular mechanisms associated with the pathogenesis of HNSCC comprise of a variety of genetic alterations such as mutations and epigenetic modifications, including methylation of CpG islands. In addition, the epigenetic modification resulting in the alteration of expression of tumor-related genes is considered crucial in the development of HNSCC [<xref ref-type="bibr" rid="pone.0173194.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0173194.ref004">4</xref>].</p>
<p>The promoter methylation of the tumor suppressor gene (TSG) leads to gene inactivation, which reduces or inhibits the function of the tumor suppressor. Hypermethylation of the tumor suppressor gene occurs in cancer development for many types of cancers including HNSCC. The death-associated protein kinase (<italic>DAPK</italic>) is a tumor suppressor gene, which is a mediator of cell death of INF-γ–induced apoptosis [<xref ref-type="bibr" rid="pone.0173194.ref005">5</xref>–<xref ref-type="bibr" rid="pone.0173194.ref007">7</xref>]. The decreased expression of <italic>DAPK</italic> is associated with the methylation of gene promoter [<xref ref-type="bibr" rid="pone.0173194.ref008">8</xref>,<xref ref-type="bibr" rid="pone.0173194.ref009">9</xref>]. The methylation of <italic>DAPK</italic> promoter has been found to be an important epigenetic modification in several types of cancers [<xref ref-type="bibr" rid="pone.0173194.ref010">10</xref>–<xref ref-type="bibr" rid="pone.0173194.ref012">12</xref>].</p>
<p>Aberrant methylation of <italic>DAPK</italic> promoter has been reported in patients with HNSCC. However, the results are inconsistent. There are significant differences in the frequency of <italic>DAPK</italic> promoter methylationin patients with HNSCC. Moreover, whether the methylation frequency of <italic>DAPK</italic> promoter is correlated with clinicopathological features (sex, smoking status, alcohol status and lymph node invasion) in HNSCC patients remains unclear. Thus, we performed the meta-analysis to investigate the relationship between the methylation status of <italic>DAPK</italic> promoter and HNSCC, as well as the relationship between <italic>DAPK</italic> promoter methylation and clinicopathological features of HNSCC.</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>Materials and methods</title>
<p>The meta-analysis was performed according to the latest meta-analysis guidelines (PRISMA) [<xref ref-type="bibr" rid="pone.0173194.ref013">13</xref>].</p>
<sec id="sec007">
<title>Search strategy</title>
<p>Systematic review of relevant literature was conducted using PubMed, Web of Science, Ovid, and Embase databases from January 1, 1968, to June 30, 2016. The keywords used for the literature search were: (<italic>DAPK</italic> methylation) and (head and neck or oral or tonsil ororopharyngeal or laryngeal or oropharynx) and (squamous cell carcinoma or cancer).</p>
</sec>
<sec id="sec008">
<title>Inclusion and exclusion criteria of literature</title>
<p>The studies were included if they satisfied the following inclusion criteria: (1) investigated the correlation between <italic>DAPK</italic> promoter methylation and HNSCC or investigated the correlation between <italic>DAPK</italic> promoter methylation and clinicopathological features,(2) specimens of case group (HNSCC) were limited to tissues, (3) the <italic>DAPK</italic> promoter methylation frequency and sample size provided in the case and the control groups.</p>
<p>Only studies written in English were included for review. In addition, case reports, abstracts, and letters to the editor were eliminated.</p>
</sec>
<sec id="sec009">
<title>Data extraction and quality assessment</title>
<p>The relevant data from the eligible studies were independently retrieved by two authors (Fucheng Cai and Yi Zhong). The relevant data include the name of the first author, year of publication, region of study subjects, age of patients, methylation detection method, source of control, type of samples in the control group, number of people with <italic>DAPK</italic> methylation in case and control groups, and sample size of case and control groups. Moreover, we also extracted the number of individuals with <italic>DAPK</italic> methylation in clinical features’ subgroups in the studies investigating the correlation between <italic>DAPK</italic> promoter methylation and clinical characteristics of HNSCC. The third reviewer (Xiyue Xiao) independently reviewed the relevant data extracted from the eligible studies.</p>
</sec>
<sec id="sec010">
<title>Statistical analysis</title>
<p>The strength of the association between <italic>DAPK</italic> promoter methylation and HNSCC was evaluated by odds ratio (OR) with 95% confidence intervals (CIs).The degree of association between <italic>DAPK</italic> promoter methylation and clinicopathological features was also evaluated by OR with 95%CI.The heterogeneity among the included studies was estimated by the Cochran Q test and <italic>I</italic><sup><italic>2</italic></sup> statistics [<xref ref-type="bibr" rid="pone.0173194.ref014">14</xref>].The random-effects model was used to compute the pooled ORs when the heterogeneity was considered significant (<italic>P</italic>&lt;0.05 for the Q statistic). In the case of a different scenario, a fixed-effects model was applied to compute the pooled ORs. To explore the potential source of heterogeneity among the included studies, meta-regression analyses, and subgroup analyses were conducted. A sensitivity analysis was employed to assess the influence of each study excluded in the combined OR. The publication bias was assessed by the Begg’s funnel plot [<xref ref-type="bibr" rid="pone.0173194.ref015">15</xref>]and Egger’s test [<xref ref-type="bibr" rid="pone.0173194.ref016">16</xref>]. The reported P values were two-sided for all the analyses. 0.5 is added as a default to all 0 counts when the 2×2 table for the individual studies contains cells with 0 counts in the Meta package. All statistical tests were performed using the Meta package in R (version 3.2.3; <ext-link ext-link-type="uri" xlink:href="http://www.r-project.org/" xlink:type="simple">http://www.r-project.org/</ext-link>).</p>
</sec>
</sec>
<sec id="sec011" sec-type="results">
<title>Results</title>
<sec id="sec012">
<title>Identification of studies and study characteristics</title>
<p>A total of 188 studies were initially identified by literature search. The duplicates and non-relevant studies (reviews and animal and cell studies) were excluded by considering the title and abstract of the studies. 28 articles with potentially relevant studies were further identified by examining the full text. Finally, 18 studies were included in the meta-analysis after excluding studies without methylation frequency and tissues in the case group. The detailed study selection process is illustrated in <xref ref-type="fig" rid="pone.0173194.g001">Fig 1</xref>.</p>
<fig id="pone.0173194.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0173194.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Flow chart of studies included in the meta-analysis.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0173194.g001" xlink:type="simple"/>
</fig>
<p>Out of the 18 studies included, 15 studies with 818 cases and 852 controls were combined to calculate the pooled OR between <italic>DAPK</italic> promoter methylation and HNSCC. The 15 studies encompassed the publication years from 2002–2015. The methylation detection methods consisted of the methylation-specific polymerase chain reaction (MSP), real-time quantitative MSP (QMSP), and bisulfite sequencing PCR (BSP). Among the 15 included studies, 10 studies used MSP, 4 studies used QMSP and 1 study used BSP to explore <italic>DAPK</italic> promoter methylation in HNSCC and corresponding control. Eight studies were of Asian subjects and seven studies were of non-Asian subjects. The sample of controls consisted of tissue, blood, saliva, and buccal scrapings. The control source contained autologous and heterogeneous controls. The detail study characteristics were summarized in <xref ref-type="table" rid="pone.0173194.t001">Table 1</xref>.</p>
<table-wrap id="pone.0173194.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0173194.t001</object-id>
<label>Table 1</label> <caption><title>Characteristics of studies included in the meta-analysis of <italic>DAPK</italic> promoter methylation and HNSCC.</title></caption>
<alternatives>
<graphic id="pone.0173194.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0173194.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="2">author</th>
<th align="left" rowspan="2">year</th>
<th align="left" rowspan="2">region</th>
<th align="center" rowspan="2">age (case, years)</th>
<th align="center" colspan="2">case</th>
<th align="center" colspan="2">control</th>
<th align="left" rowspan="2">method<xref ref-type="table-fn" rid="t001fn002"><sup>#</sup></xref></th>
<th align="left" rowspan="2">control source<xref ref-type="table-fn" rid="t001fn003">*</xref></th>
<th align="left" rowspan="2">control sample</th>
</tr>
<tr>
<th align="center">M</th>
<th align="center">U</th>
<th align="center">M</th>
<th align="center">U</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Arantes, L. M.[<xref ref-type="bibr" rid="pone.0173194.ref021">21</xref>]</td>
<td align="right">2015</td>
<td align="left">Brazil</td>
<td align="left">median = 54.5;range:41–78</td>
<td align="right">32</td>
<td align="right">8</td>
<td align="right">8</td>
<td align="right">32</td>
<td align="left">QMSP</td>
<td align="left">H</td>
<td align="left">saliva</td>
</tr>
<tr>
<td align="left">Choudhury, J. H.[<xref ref-type="bibr" rid="pone.0173194.ref022">22</xref>]</td>
<td align="right">2015</td>
<td align="left">India</td>
<td align="left">range:23–86</td>
<td align="right">21</td>
<td align="right">50</td>
<td align="right">5</td>
<td align="right">40</td>
<td align="left">MSP</td>
<td align="left">A</td>
<td align="left">tissue</td>
</tr>
<tr>
<td align="left">Rettori, M. M.[<xref ref-type="bibr" rid="pone.0173194.ref023">23</xref>]</td>
<td align="right">2013</td>
<td align="left">Brazil</td>
<td align="left">median = 59;range:20–90</td>
<td align="right">35</td>
<td align="right">33</td>
<td align="right">1</td>
<td align="right">38</td>
<td align="left">QMSP</td>
<td align="left">H</td>
<td align="left">saliva</td>
</tr>
<tr>
<td align="left">Li, C.[<xref ref-type="bibr" rid="pone.0173194.ref008">8</xref>]</td>
<td align="right">2013</td>
<td align="left">China</td>
<td align="left">median = 55;range:40–72</td>
<td align="right">30</td>
<td align="right">23</td>
<td align="right">0</td>
<td align="right">23</td>
<td align="left">MSP</td>
<td align="left">H</td>
<td align="left">tissue</td>
</tr>
<tr>
<td align="left">Liu, Y.[<xref ref-type="bibr" rid="pone.0173194.ref024">24</xref>]</td>
<td align="right">2012</td>
<td align="left">China</td>
<td align="left">mean = 55.0; sd: 13.5</td>
<td align="right">15</td>
<td align="right">17</td>
<td align="right">15</td>
<td align="right">62</td>
<td align="left">QMSP</td>
<td align="left">H</td>
<td align="left">tissue</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="right">16</td>
<td align="right">61</td>
<td align="right"/>
<td align="left"/>
<td align="left">blood</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="right">2</td>
<td align="right">75</td>
<td align="right"/>
<td align="left"/>
<td align="left">saliva</td>
</tr>
<tr>
<td align="left">Paluszczak, J.[<xref ref-type="bibr" rid="pone.0173194.ref025">25</xref>]</td>
<td align="right">2011</td>
<td align="left">Poland</td>
<td align="left">mean = 58.3;range:41–75</td>
<td align="right">31</td>
<td align="right">10</td>
<td align="right">32</td>
<td align="right">9</td>
<td align="left">MSP</td>
<td align="left">A</td>
<td align="left">tissue</td>
</tr>
<tr>
<td align="left">Wong, Y.K.[<xref ref-type="bibr" rid="pone.0173194.ref026">26</xref>]</td>
<td align="right">2011</td>
<td align="left">Taiwan</td>
<td align="left">mean = 51.7;range:26–77</td>
<td align="right">29</td>
<td align="right">35</td>
<td align="right">26</td>
<td align="right">38</td>
<td align="left">MSP</td>
<td align="left">A</td>
<td align="left">tissue</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="right">0</td>
<td align="right">20</td>
<td align="right"/>
<td align="left">H</td>
<td align="left">tissue</td>
</tr>
<tr>
<td align="left">Laytragoon-Lewin, N.[<xref ref-type="bibr" rid="pone.0173194.ref027">27</xref>]</td>
<td align="right">2010</td>
<td align="left">Sweden</td>
<td align="left">median = 62;range:42–101</td>
<td align="right">7</td>
<td align="right">11</td>
<td align="right">2</td>
<td align="right">16</td>
<td align="left">MSP</td>
<td align="left">A</td>
<td align="left">tissue</td>
</tr>
<tr>
<td align="left">Su, P. F.[<xref ref-type="bibr" rid="pone.0173194.ref028">28</xref>]</td>
<td align="right">2010</td>
<td align="left">Taiwan</td>
<td align="left">mean = 54.94;range:37–82</td>
<td align="right">13</td>
<td align="right">18</td>
<td align="right">5</td>
<td align="right">26</td>
<td align="left">QMSP</td>
<td align="left">A</td>
<td align="left">tissue</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="right">0</td>
<td align="right">12</td>
<td align="right"/>
<td align="left">H</td>
<td align="left">buccal scrapings</td>
</tr>
<tr>
<td align="left">Steinmann, K.[<xref ref-type="bibr" rid="pone.0173194.ref029">29</xref>]</td>
<td align="right">2009</td>
<td align="left">Germany</td>
<td align="left">mean = 57;range:41–71</td>
<td align="right">36</td>
<td align="right">18</td>
<td align="right">8</td>
<td align="right">15</td>
<td align="left">MSP</td>
<td align="left">A</td>
<td align="left">tissue</td>
</tr>
<tr>
<td align="left">De Schutter, H.[<xref ref-type="bibr" rid="pone.0173194.ref030">30</xref>]</td>
<td align="right">2009</td>
<td align="left">Belgium</td>
<td align="left">mean = 59;range:43–76</td>
<td align="right">4</td>
<td align="right">40</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="left">MSP</td>
<td align="left">H</td>
<td align="left">tissue</td>
</tr>
<tr>
<td align="left">Righini, C. A.[<xref ref-type="bibr" rid="pone.0173194.ref031">31</xref>]</td>
<td align="right">2007</td>
<td align="left">French</td>
<td align="left">median = 57;range:33–74</td>
<td align="right">19</td>
<td align="right">71</td>
<td align="right">1</td>
<td align="right">29</td>
<td align="left">MSP</td>
<td align="left">A</td>
<td align="left">tissue</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="right">9</td>
<td align="right">51</td>
<td align="right"/>
<td align="left">A</td>
<td align="left">saliva</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="right">0</td>
<td align="right">30</td>
<td align="right"/>
<td align="left">H</td>
<td align="left">saliva</td>
</tr>
<tr>
<td align="left">Kong, W. J.[<xref ref-type="bibr" rid="pone.0173194.ref032">32</xref>]</td>
<td align="right">2005</td>
<td align="left">China</td>
<td align="left">mean = 53.3;range:32–78</td>
<td align="right">39</td>
<td align="right">19</td>
<td align="right">6</td>
<td align="right">52</td>
<td align="left">MSP</td>
<td align="left">A</td>
<td align="left">tissue</td>
</tr>
<tr>
<td align="left">Kulkarni, V.[<xref ref-type="bibr" rid="pone.0173194.ref033">33</xref>]</td>
<td align="right">2004</td>
<td align="left">India</td>
<td align="left">median = 50;range:25–71</td>
<td align="right">41</td>
<td align="right">19</td>
<td align="right">36</td>
<td align="right">24</td>
<td align="left">MSP</td>
<td align="left">A</td>
<td align="left">tissue</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="right">0</td>
<td align="right">20</td>
<td align="right"/>
<td align="left">H</td>
<td align="left">buccal scrapings</td>
</tr>
<tr>
<td align="left">Ogi, K.[<xref ref-type="bibr" rid="pone.0173194.ref017">17</xref>]</td>
<td align="right">2002</td>
<td align="left">Japan</td>
<td align="left">NA</td>
<td align="right">7</td>
<td align="right">89</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="left">BSR</td>
<td align="left">H</td>
<td align="left">tissue</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>M: <italic>DAPK</italic> promoter methylated, U: <italic>DAPK</italic> promoter unmethylated</p></fn>
<fn id="t001fn002"><p>#: MSP: methylation-specific polymerase chain reaction, QMSP: real-time quantitative MSP, BSP: Bisulfite sequencing PCR</p></fn>
<fn id="t001fn003"><p>*: A: Autologous control, H: Heterogeneous control</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Among the 18 included studies, seven studies were combined to estimate the pooled OR between <italic>DAPK</italic> promoter methylation and clinicopathological features of HNSCC from the 18 included studies. The clinicopathological features included sex, smoking status, alcohol status, and lymph node invasion. The detailed characteristics of the study were summarized in <xref ref-type="table" rid="pone.0173194.t002">Table 2</xref>.</p>
<table-wrap id="pone.0173194.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0173194.t002</object-id>
<label>Table 2</label> <caption><title>Characteristics of studies included in themeta-analysis of <italic>DAPK</italic> promoter methylation and clinicopathological features.</title></caption>
<alternatives>
<graphic id="pone.0173194.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0173194.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="2">Author</th>
<th align="left" rowspan="2">Year</th>
<th align="left" rowspan="2">Region</th>
<th align="left" rowspan="2">Method<xref ref-type="table-fn" rid="t002fn002"><sup>#</sup></xref></th>
<th align="left" colspan="2">Sex</th>
<th align="left" colspan="2">Smoking</th>
<th align="left" colspan="2">Alcohol</th>
<th align="left" colspan="2">N_stage<xref ref-type="table-fn" rid="t002fn003">*</xref></th>
</tr>
<tr>
<th align="left">Male (M/U)</th>
<th align="left">Female (M/U)</th>
<th align="left">Smoker (M/U)</th>
<th align="left">Non-smoker (M/U)</th>
<th align="left">Yes (M/U)</th>
<th align="left">No (M/U)</th>
<th align="left">N0 (M/U)</th>
<th align="left">N+ (M/U)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Misawa, K.[<xref ref-type="bibr" rid="pone.0173194.ref034">34</xref>]</td>
<td align="right">2016</td>
<td align="left">Japan</td>
<td align="left">QMSP</td>
<td align="left">54/55</td>
<td align="left">17/7</td>
<td align="left">53/42</td>
<td align="left">18/20</td>
<td align="left">51/36</td>
<td align="left">20/26</td>
<td align="left">31/28</td>
<td align="left">31/28</td>
</tr>
<tr>
<td align="left">Arantes, L. M.[<xref ref-type="bibr" rid="pone.0173194.ref021">21</xref>]</td>
<td align="right">2015</td>
<td align="left">Brazil</td>
<td align="left">QMSP</td>
<td align="left">29/7</td>
<td align="left">3/1</td>
<td align="left">26/3</td>
<td align="left">6/5</td>
<td align="left">22/4</td>
<td align="left">10/4</td>
<td align="left">9/2</td>
<td align="left">23/6</td>
</tr>
<tr>
<td align="left">Pierini, S.[<xref ref-type="bibr" rid="pone.0173194.ref035">35</xref>]</td>
<td align="right">2014</td>
<td align="left">Bulgaria</td>
<td align="left">MS-HRM</td>
<td align="left">37/54</td>
<td align="left">4/2</td>
<td align="left">28/44</td>
<td align="left">13/12</td>
<td align="left"/>
<td align="left"/>
<td align="left">29/43</td>
<td align="left">12/13</td>
</tr>
<tr>
<td align="left">Wong, Y.K.[<xref ref-type="bibr" rid="pone.0173194.ref026">26</xref>]</td>
<td align="right">2011</td>
<td align="left">Taiwan</td>
<td align="left">MSP</td>
<td align="left">25/33</td>
<td align="left">4/2</td>
<td align="left">20/30</td>
<td align="left">7/7</td>
<td align="left">18/22</td>
<td align="left">5/9</td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">Su, P. F.[<xref ref-type="bibr" rid="pone.0173194.ref028">28</xref>]</td>
<td align="right">2010</td>
<td align="left">Taiwan</td>
<td align="left">QMSP</td>
<td align="left">12/17</td>
<td align="left">2/2</td>
<td align="left">11/13</td>
<td align="left">3/5</td>
<td align="left">8/9</td>
<td align="left">3/8</td>
<td align="left">5/6</td>
<td align="left">9/13</td>
</tr>
<tr>
<td align="left">Supic, G.[<xref ref-type="bibr" rid="pone.0173194.ref036">36</xref>]</td>
<td align="right">2009</td>
<td align="left">Serbia</td>
<td align="left">MSP</td>
<td align="left">25/39</td>
<td align="left">3/10</td>
<td align="left">22/39</td>
<td align="left">6/10</td>
<td align="left"/>
<td align="left"/>
<td align="left">4/12</td>
<td align="left">24/37</td>
</tr>
<tr>
<td align="left">Kulkarni, V.[<xref ref-type="bibr" rid="pone.0173194.ref033">33</xref>]</td>
<td align="right">2004</td>
<td align="left">India</td>
<td align="left">MSP</td>
<td align="left">29/15</td>
<td align="left">12/4</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left">22/10</td>
<td align="left">19/9</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>M: <italic>DAPK</italic> promoter methylated, U: <italic>DAPK</italic> promoter unmethylated</p></fn>
<fn id="t002fn002"><p>#: MSP: methylation-specific polymerase chain reaction, QMSP: real-time quantitative MSP, MS_HRM: Methylation-sensitive high resolution melting</p></fn>
<fn id="t002fn003"><p>*: N_stage: lymph node invasion</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec013">
<title>Association between <italic>DAPK</italic> promoter methylation and HNSCC</title>
<p>In the meta-analysis, the heterogeneity among the included studies was significant for Q test (P&lt;0.001). Thus, the random-effect model was employed to evaluate the summary of ORs. In the random-effect model, we found that <italic>DAPK</italic> promoter methylation was significantly associated with HNSCC (pooled OR = 3.96,95%CI = 2.26–6.95) (<xref ref-type="fig" rid="pone.0173194.g002">Fig 2</xref>).</p>
<fig id="pone.0173194.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0173194.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Forest plots of <italic>DAPK</italic> promoter methylation associated with HNSCC.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0173194.g002" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec014">
<title>Association between <italic>DAPK</italic> promoter methylation with clinicopathological features</title>
<p>The meta-analysis result suggested that the frequency of DAPK promoter methylation in patients with HNSCC was significantly higher than the corresponding controls (<xref ref-type="fig" rid="pone.0173194.g002">Fig 2</xref>).Therefore, we also assessed the association between <italic>DAPK</italic> promoter methylation and the clinicopathological features. Among the included studies, the smoking group was divided into three groups (Current, Former, and Never) in three studies. The smoking group in the three studies was divided into two groups (Smoker and Non-smoker). To pool the data, the Current group was classified as Smoker group, and the Former and Never groups were classified as Non-smoker group. In the meta-analysis, <italic>DAPK</italic> promoter methylation was not significantly correlated with sex, smoking status, and lymph node invasion (<xref ref-type="fig" rid="pone.0173194.g003">Fig 3A, 3B and 3D</xref>). However, the meta-analysis found that <italic>DAPK</italic> promoter methylation was significantly correlated with the alcohol status (OR = 1.85, 95% CI = 1.07–3.21) (<xref ref-type="fig" rid="pone.0173194.g003">Fig 3C</xref>).</p>
<fig id="pone.0173194.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0173194.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Forest plots of <italic>DAPK</italic> promoter methylation associated with clinicopathological features</title>
<p>A: Forest plots of <italic>DAPK</italic> promoter methylation associated with sex B: Forest plots of <italic>DAPK</italic> promoter methylation associated with smoking status C: Forest plots of <italic>DAPK</italic> promoter methylation associated with alcohol status D: Forest plots of <italic>DAPK</italic> promoter methylation associated with lymph node invasion.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0173194.g003" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec015">
<title>Meta-regression analysis and subgroup analysis</title>
<p>The meta-regression analysis was used to explore the potential sources of heterogeneity among the included studies. We found that the possible source of heterogeneity was the method (<italic>P</italic> = 0.04) according to the meta-regression analysis (<xref ref-type="table" rid="pone.0173194.t003">Table 3</xref>). To further assess the potential sources, we conducted the subgroup analysis according to the region, methylation detection method, control source, control sample type, and sample size of the case group.</p>
<table-wrap id="pone.0173194.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0173194.t003</object-id>
<label>Table 3</label> <caption><title>Meta-regression analysisof <italic>DAPK</italic> promoter methylation and HNSCC.</title></caption>
<alternatives>
<graphic id="pone.0173194.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0173194.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center"/>
<th align="center"/>
<th align="center">95%CI</th>
<th align="center"/>
<th align="center"/>
</tr>
<tr>
<th align="center">Heterogeneity sources</th>
<th align="center">Coefficient</th>
<th align="center">Lower</th>
<th align="center">Upper</th>
<th align="center"><italic>P</italic></th>
</tr>
</thead>
<tbody>
<tr>
<td align="center">Publication year</td>
<td align="right">0.062</td>
<td align="center">-0.115</td>
<td align="center">0.239</td>
<td align="center">0.495</td>
</tr>
<tr>
<td align="center">Region</td>
<td align="right">-0.881</td>
<td align="center">-2.125</td>
<td align="center">0.363</td>
<td align="center">0.165</td>
</tr>
<tr>
<td align="center">Method</td>
<td align="right">-1.825</td>
<td align="center">-3.590</td>
<td align="center">-0.060</td>
<td align="center">0.043</td>
</tr>
<tr>
<td align="center">Case sample size</td>
<td align="right">-0.767</td>
<td align="center">-2.113</td>
<td align="center">0.580</td>
<td align="center">0.265</td>
</tr>
<tr>
<td align="center">Control source</td>
<td align="right">1.256</td>
<td align="center">-0.417</td>
<td align="center">2.929</td>
<td align="center">0.141</td>
</tr>
<tr>
<td align="center">Control sample</td>
<td align="right">-1.474</td>
<td align="center">-3.033</td>
<td align="center">0.086</td>
<td align="center">0.064</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<p>With respect to the subgroups categorized by the region, significant association between <italic>DAPK</italic> promoter methylation and HNSCC was found among the Asian region and the Non-Asia region in the random-effect model (Asian region, OR = 4.43, 95% CI = 2.29–8.58; Non-Asia region, OR = 3.39, 95% CI = 1.18–9.78).The heterogeneity did not decrease remarkably among the region-based subgroup. In the methylation detection method group, Ogi et al.[<xref ref-type="bibr" rid="pone.0173194.ref017">17</xref>] used bisulfite-PCR (BSP) to detect methylation and was classified as the MSP group.</p>
<p>The significant association between <italic>DAPK</italic> promoter methylation and HNSCC was displayed among the MSP in the random-effect model and the QMSP in the fixed-effect model (MSP, OR = 2.97, 95% CI = 1.55–5.70; QMSP, OR = 8.84, 95% CI = 5.22–14.99). In the control source, the significant association between <italic>DAPK</italic> promoter methylation and HNSCC was seen among the autologous group and the heterogeneous group in the random-effect model (autologous group, OR = 2.71, 95% CI = 1.49–4.93; heterogeneous group, OR = 9.50, 95% CI = 2.98–30.27). With the control sample type, a significant association between <italic>DAPK</italic> promoter methylation and HNSCC was found among the tissue group and the non-tissue group in the random-effect model (tissue group, OR = 3.95, 95% CI = 1.89–8.25; non-tissue group, OR = 5.30, 95% CI = 2.17–12.93). With the sample size in the cases, significant association between <italic>DAPK</italic> promoter methylation and HNSCC was found among the &lt;60group in random-effect model and the ≥60 group in the fixed-effect model (&lt;60 group, OR = 4.64, 95% CI = 1.94–11.06; ≥60 group, OR = 3.12, 95% CI = 2.17–4.49). The subgroup analysis of <italic>DAPK</italic> promoter methylation associated with HNSCC was summarized in <xref ref-type="table" rid="pone.0173194.t004">Table 4</xref>.</p>
<table-wrap id="pone.0173194.t004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0173194.t004</object-id>
<label>Table 4</label> <caption><title>Summary of the subgroup analysisin the meta-analysis of <italic>DAPK</italic> promoter methylation and HNSCC.</title></caption>
<alternatives>
<graphic id="pone.0173194.t004g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0173194.t004" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" rowspan="2">Group</th>
<th align="center" colspan="2">Case</th>
<th align="center" colspan="2">Control</th>
<th align="center">Fixed-effects model</th>
<th align="center">Random-effects model</th>
<th align="center" colspan="3">Heterogeneity</th>
</tr>
<tr>
<th align="center">M+</th>
<th align="center">N</th>
<th align="center">M+</th>
<th align="center">N</th>
<th align="center">OR (95%CI)</th>
<th align="center">OR (95%CI)</th>
<th align="center"><italic>I</italic><sup><italic>2</italic></sup> (%)</th>
<th align="center"><italic>P</italic></th>
<th align="center">τ<sup>2</sup></th>
</tr>
</thead>
<tbody>
<tr>
<td align="right">Total</td>
<td align="left">359</td>
<td align="left">820</td>
<td align="left">174</td>
<td align="left">852</td>
<td align="left">4.09 (3.17–5.28)</td>
<td align="left">3.96 (2.26–6.95)</td>
<td align="left">72.7</td>
<td align="left">&lt;0.001</td>
<td align="left">0.79</td>
</tr>
<tr>
<td align="right">Region</td>
<td align="right"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="right">Asia</td>
<td align="left">195</td>
<td align="left">465</td>
<td align="left">111</td>
<td align="left">566</td>
<td align="left">4.21 (3.04–5.84)</td>
<td align="left">4.43 (2.29–8.58)</td>
<td align="left">67.4</td>
<td align="left">0.003</td>
<td align="left">0.53</td>
</tr>
<tr>
<td align="right">Non-asia</td>
<td align="left">164</td>
<td align="left">355</td>
<td align="left">63</td>
<td align="left">286</td>
<td align="left">3.91 (2.60–5.90)</td>
<td align="left">3.39 (1.18–9.78)</td>
<td align="left">79.8</td>
<td align="left">&lt;0.001</td>
<td align="left">1.53</td>
</tr>
<tr>
<td align="right">Method</td>
<td align="right"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="right">MSP</td>
<td align="left">257</td>
<td align="left">553</td>
<td align="left">127</td>
<td align="left">497</td>
<td align="left">3.18 (2.37–4.28)</td>
<td align="left">2.97 (1.55–5.70)</td>
<td align="left">72.8</td>
<td align="left">&lt;0.001</td>
<td align="left">0.72</td>
</tr>
<tr>
<td align="right">QMSP</td>
<td align="left">102</td>
<td align="left">267</td>
<td align="left">47</td>
<td align="left">355</td>
<td align="left">8.84 (5.22–14.99)</td>
<td align="left">7.73 (3.09–19.36)</td>
<td align="left">56.4</td>
<td align="left">0.06</td>
<td align="left">0.56</td>
</tr>
<tr>
<td align="right">Control source</td>
<td align="right"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="right">Autologous</td>
<td align="left">236</td>
<td align="left">487</td>
<td align="left">130</td>
<td align="left">430</td>
<td align="left">2.49 (1.84–3.36)</td>
<td align="left">2.71 (1.49–4.93)</td>
<td align="left">70.3</td>
<td align="left">0.001</td>
<td align="left">0.56</td>
</tr>
<tr>
<td align="right">Heterogeneous</td>
<td align="left">225</td>
<td align="left">578</td>
<td align="left">44</td>
<td align="left">442</td>
<td align="left">11.46 (6.85–19.18)</td>
<td align="left">9.50 (2.98–30.27)</td>
<td align="left">70.8</td>
<td align="left">&lt;0.001</td>
<td align="left">2.12</td>
</tr>
<tr>
<td align="right">Control sample type<sup>$</sup></td>
<td align="right"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="right">Tissue</td>
<td align="left">292</td>
<td align="left">712</td>
<td align="left">138</td>
<td align="left">497</td>
<td align="left">3.41 (2.55–4.54)</td>
<td align="left">3.95 (1.89–8.25)</td>
<td align="left">75.4</td>
<td align="left">&lt;0.001</td>
<td align="left">1.14</td>
</tr>
<tr>
<td align="right">Non-tissue</td>
<td align="left">155</td>
<td align="left">321</td>
<td align="left">36</td>
<td align="left">355</td>
<td align="left">6.31 (4.09–9.73)</td>
<td align="left">5.30 (2.17–12.93)</td>
<td align="left">69.8</td>
<td align="left">0.002</td>
<td align="left">1.03</td>
</tr>
<tr>
<td align="right">Case sample size</td>
<td align="right"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="right">&lt;60</td>
<td align="left">207</td>
<td align="left">371</td>
<td align="left">96</td>
<td align="left">482</td>
<td align="left">5.35 (3.72–7.71)</td>
<td align="left">4.64 (1.94–11.06)</td>
<td align="left">77.8</td>
<td align="left">&lt;0.001</td>
<td align="left">1.27</td>
</tr>
<tr>
<td align="right">≥60</td>
<td align="left">152</td>
<td align="left">449</td>
<td align="left">78</td>
<td align="left">370</td>
<td align="left">3.12 (2.17–4.49)</td>
<td align="left">2.94 (1.60–5.38)</td>
<td align="left">50.9</td>
<td align="left">0.070</td>
<td align="left">0.26</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t004fn001"><p>M+: <italic>DAPK</italic> promoter methylated</p></fn>
<fn id="t004fn002"><p>N: total number</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec016">
<title>Sensitivity analysis</title>
<p>The sensitivity analysis was performed to evaluate the stability of the conclusions according to the leave-one-out method by excluding one study. The pooled OR was changed from 3.47 (95%CI = 2.01–6.00) to 4.53(95%CI = 2.67–7.70) under the random-effect model, which confirms the stability of the results (<xref ref-type="fig" rid="pone.0173194.g004">Fig 4</xref>). Therefore, the result of the meta-analysis was stable and reliable.</p>
<fig id="pone.0173194.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0173194.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Sensitivity analysis of <italic>DAPK</italic> promoter methylation and HNSCC by the random-effects method.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0173194.g004" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec017">
<title>Publication bias</title>
<p>Publication bias of the included studies was assessed through the Begg’s funnel plot and Egger’s test. The shape of the Begg’s funnel plot did not reveal any potential asymmetry (<xref ref-type="fig" rid="pone.0173194.g005">Fig 5</xref>). The publication bias detected by Egger’s test was not significant (<italic>P</italic> = 0.55).</p>
<fig id="pone.0173194.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0173194.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Begg’s funnel plot of <italic>DAPK</italic> promoter methylation associated with HNSCC.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0173194.g005" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec018" sec-type="conclusions">
<title>Discussion</title>
<p>Hypermethylation of the promoter of the tumor suppressor gene (TSG) resulted in silencing the expression of TSGs in carcinogenesis of the tumor. Death-associated protein kinase (<italic>DAPK</italic>), a tumor suppressor gene, could mediate cell death in INF-γ–induced apoptosis, whereas inactivated <italic>DAPK</italic>, could lead to the pathogenesis and metastasis of the tumor [<xref ref-type="bibr" rid="pone.0173194.ref018">18</xref>]. The loss of expression of <italic>DAPK</italic> mainly induced by methylation of its promoter plays a crucial role in the carcinogenesis of the tumor [<xref ref-type="bibr" rid="pone.0173194.ref019">19</xref>].</p>
<p>The present meta-analysis including 15 studies was performed to quantitatively assess the strength of association of DAPK promoter methylation and HNSCC. The overall frequency of DAPK promoter methylation in patients with HNSCC was 43.64% and 20.42% in the control population. The results of the meta-analysis suggested that individuals with hypermethylation of DAPK promoter are associated with HNSCC (pooled OR = 3.96, 95%CI = 2.26–6.95).</p>
<p>A significant heterogeneity between the studies was found by Q-test in the meta-analysis. The subgroup analysis was conducted to explore the potential heterogeneity among the included studies in our meta-analysis; a significant association between <italic>DAPK</italic> methylation and HNSCC was found in all the subgroup (<xref ref-type="table" rid="pone.0173194.t004">Table 4</xref>). In the methylation detection method group, a significant association between <italic>DAPK</italic> promoter methylation and HNSCC was observed among the MSP in the random-effect model and the QMSP in the fixed-effect model (MSP, OR = 2.97, 95% CI = 1.55–5.70; QMSP, OR = 8.84, 95% CI = 5.22–14.99). The pooled ORs in QMSP were higher than in the MSP. The phenomenon could be attributed tothe specificity and sensitivity of QMSP detecting up to 1/1000 methylated alleles more than the conventional MSP [<xref ref-type="bibr" rid="pone.0173194.ref020">20</xref>]. With the control source, the significant association between <italic>DAPK</italic> promoter methylation and HNSCC was found among the autologous group and the heterogeneous group in the random-effect model (autologous group, OR = 2.71, 95% CI = 1.49–4.93; heterogeneous group, OR = 9.50, 95% CI = 2.98–30.27).The results suggested that the frequency of <italic>DAPK</italic> promoter methylationin the autologous control was higher than the heterogeneous control. This indicated that the <italic>DAPK</italic> promoter methylation might play a crucial role in the pathogenesis of HNSCC.</p>
<p>We also investigated the correlation between the <italic>DAPK</italic> promoter methylation and the clinicopathological features. The results suggested that <italic>DAPK</italic> promoter methylation was significantly correlated with the alcohol status. The drinkers have a 1.85-fold increased <italic>DAPK</italic> methylation frequency compared with the non-drinkers (OR = 1.85, 95% CI = 1.07–3.21). The <italic>DAPK</italic> promoter methylation was not significantly correlated with sex, smoking, and lymph node invasion.</p>
<p>However, the present meta-analysis exhibited some limitations. First, a limited number of articles were included in the meta-analysis for assessing the correlation between <italic>DAPK</italic> promoter methylation and clinicopathological features. Thus, the accurate and reasonable conclusions need to be confirmed in future studies. Second, although the publication bias was not significant according to Egger’s test, some unpublished studies and non-English language studies may contribute to some bias.</p>
<p>In conclusion, the present study found that aberrant methylation of <italic>DAPK</italic> promoter was associated with HNSCC, which suggested that the promoter methylation of <italic>DAPK</italic> plays a crucial role in the development of HNSCC. However, well-designed studies with larger sample size may be performed in order to further confirm the correlation between <italic>DAPK</italic> promoter methylation and HNSCC.</p>
</sec>
<sec id="sec019">
<title>Supporting information</title>
<supplementary-material id="pone.0173194.s001" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0173194.s001" xlink:type="simple">
<label>S1 Checklist</label>
<caption>
<title>PRISMA 2009 checklist.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0173194.s002" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0173194.s002" xlink:type="simple">
<label>S2 Checklist</label>
<caption>
<title>Meta-analysis-on-genetic-association-studies checklist.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0173194.s003" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0173194.s003" xlink:type="simple">
<label>S3 Checklist</label>
<caption>
<title>PLOS One clinical studies checklist.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="pone.0173194.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Siegel</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Ma</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zou</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Jemal</surname> <given-names>A</given-names></name>. <article-title>Cancer statistics, 2014</article-title>. <source>CA Cancer J Clin</source>. <year>2014</year>; <volume>64</volume>(<issue>1</issue>):<fpage>9</fpage>–<lpage>29</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3322/caac.21208" xlink:type="simple">10.3322/caac.21208</ext-link></comment> <object-id pub-id-type="pmid">24399786</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leemans</surname> <given-names>CR</given-names></name>, <name name-style="western"><surname>Braakhuis</surname> <given-names>BJ</given-names></name>, <name name-style="western"><surname>Brakenhoff</surname> <given-names>RH</given-names></name>. <article-title>The molecular biology of head and neck cancer</article-title>. <source>Nat Rev Cancer</source>. <year>2011</year>; <volume>11</volume>(<issue>1</issue>):<fpage>9</fpage>–<lpage>22</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrc2982" xlink:type="simple">10.1038/nrc2982</ext-link></comment> <object-id pub-id-type="pmid">21160525</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guerrero-Preston</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Michailidi</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Marchionni</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Pickering</surname> <given-names>CR</given-names></name>, <name name-style="western"><surname>Frederick</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Myers</surname> <given-names>JN</given-names></name>, <etal>et al</etal>. <article-title>Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer</article-title>. <source>Epigenetics</source>. <year>2014</year>; <volume>9</volume>(<issue>7</issue>):<fpage>1031</fpage>–<lpage>1046</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4161/epi.29025" xlink:type="simple">10.4161/epi.29025</ext-link></comment> <object-id pub-id-type="pmid">24786473</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Misawa</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Misawa</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kanazawa</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Uehara</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Endo</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Mochizuki</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer</article-title>. <source>Cancer</source>. <year>2014</year>; <volume>120</volume>(<issue>2</issue>):<fpage>205</fpage>–<lpage>213</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/cncr.28411" xlink:type="simple">10.1002/cncr.28411</ext-link></comment> <object-id pub-id-type="pmid">24122450</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gozuacik</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Kimchi</surname> <given-names>A</given-names></name>. <article-title>DAPk protein family and cancer</article-title>. <source>Autophagy</source>. <year>2006</year>; <volume>2</volume>(<issue>2</issue>):<fpage>74</fpage>–<lpage>79</lpage>. <object-id pub-id-type="pmid">17139808</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cohen</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Inbal</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Kissil</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Raveh</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Berissi</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Spivak-Kroizaman</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>DAP-kinase participates in TNF-alpha- and Fas-induced apoptosis and its function requires the death domain</article-title>. <source>J Cell Biol</source>. <year>1999</year>; <volume>146</volume>(<issue>1</issue>):<fpage>141</fpage>–<lpage>148</lpage>. <object-id pub-id-type="pmid">10402466</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Velentza</surname> <given-names>AV</given-names></name>, <name name-style="western"><surname>Schumacher</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Weiss</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Egli</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Watterson</surname> <given-names>DM</given-names></name>. <article-title>A protein kinase associated with apoptosis and tumor suppression: structure, activity, and discovery of peptide substrates</article-title>. <source>J Biol Chem</source>. <year>2001</year>; <volume>276</volume>(<issue>42</issue>):<fpage>38956</fpage>–<lpage>38965</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M104273200" xlink:type="simple">10.1074/jbc.M104273200</ext-link></comment> <object-id pub-id-type="pmid">11483604</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Su</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Fu</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>Y</given-names></name>. <article-title>mRNA expression and hypermethylation of tumor suppressor genes apoptosis protease activating factor-1 and death-associated protein kinase in oral squamous cell carcinoma</article-title>. <source>Oncol Lett</source>. <year>2013</year>; <volume>6</volume>(<issue>1</issue>):<fpage>280</fpage>–<lpage>286</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3892/ol.2013.1353" xlink:type="simple">10.3892/ol.2013.1353</ext-link></comment> <object-id pub-id-type="pmid">23946818</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Christoph</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Kempkensteffen</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Weikert</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kollermann</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Krause</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Miller</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer</article-title>. <source>Br J Cancer</source>. <year>2006</year>; <volume>95</volume>(<issue>12</issue>):<fpage>1701</fpage>–<lpage>1707</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/sj.bjc.6603482" xlink:type="simple">10.1038/sj.bjc.6603482</ext-link></comment> <object-id pub-id-type="pmid">17133271</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bai</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Silencing DNA methyltransferase 1 (DNMT1) inhibits proliferation, metastasis and invasion in ESCC by suppressing methylation of RASSF1A and DAPK</article-title>. <source>Oncotarget</source>. <year>2016</year>.</mixed-citation></ref>
<ref id="pone.0173194.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Promoter hypermethylation of PTPL1, PTPN6, DAPK, p16 and 5-azacitidine inhibits growth in DLBCL</article-title>. <source>Oncol Rep</source>. <year>2016</year>; <volume>35</volume>(<issue>1</issue>):<fpage>139</fpage>–<lpage>146</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3892/or.2015.4347" xlink:type="simple">10.3892/or.2015.4347</ext-link></comment> <object-id pub-id-type="pmid">26498513</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Niklinska</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Naumnik</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Sulewska</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kozlowski</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Pankiewicz</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Milewski</surname> <given-names>R</given-names></name>. <article-title>Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC)</article-title>. <source>Folia Histochem Cytobiol</source>. <year>2009</year>; <volume>47</volume>(<issue>2</issue>):<fpage>275</fpage>–<lpage>280</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2478/v10042-009-0091-2" xlink:type="simple">10.2478/v10042-009-0091-2</ext-link></comment> <object-id pub-id-type="pmid">19926549</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref013"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Liberati A, Altman Dg Fau—Tetzlaff J, Tetzlaff J Fau—Mulrow C, Mulrow C Fau—Gotzsche PC, Gotzsche Pc Fau—Ioannidis JPA, Ioannidis Jp Fau—Clarke M, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. (1756–1833 (Electronic)).</mixed-citation></ref>
<ref id="pone.0173194.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname> <given-names>SG</given-names></name>. <article-title>Quantifying heterogeneity in a meta-analysis</article-title>. <source>Stat Med</source>. <year>2002</year>; <volume>21</volume>(<issue>11</issue>):<fpage>1539</fpage>–<lpage>1558</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/sim.1186" xlink:type="simple">10.1002/sim.1186</ext-link></comment> <object-id pub-id-type="pmid">12111919</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname> <given-names>M</given-names></name>. <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source>. <year>1994</year>; <volume>50</volume>(<issue>4</issue>):<fpage>1088</fpage>–<lpage>1101</lpage>. <object-id pub-id-type="pmid">7786990</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Davey Smith</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Schneider</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname> <given-names>C</given-names></name>. <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>Bmj</source>. <year>1997</year>; <volume>315</volume>(<issue>7109</issue>):<fpage>629</fpage>–<lpage>634</lpage>. <object-id pub-id-type="pmid">9310563</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ogi</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Toyota</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ohe-Toyota</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Tanaka</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Noguchi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sonoda</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma</article-title>. <source>Clin Cancer Res</source>. <year>2002</year>; <volume>8</volume>(<issue>10</issue>):<fpage>3164</fpage>–<lpage>3171</lpage>. <object-id pub-id-type="pmid">12374684</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Inbal</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Cohen</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Polak-Charcon</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kopolovic</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Vadai</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Eisenbach</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>DAP kinase links the control of apoptosis to metastasis</article-title>. <source>Nature</source>. <year>1997</year>; <volume>390</volume>(<issue>6656</issue>):<fpage>180</fpage>–<lpage>184</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/36599" xlink:type="simple">10.1038/36599</ext-link></comment> <object-id pub-id-type="pmid">9367156</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Su</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Fu</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>Y</given-names></name>. <article-title>mRNA expression and hypermethylation of tumor suppressor genes apoptosis protease activating factor-1 and death-associated protein kinase in oral squamous cell carcinoma</article-title>. <source>Oncology Letters</source>. <year>2013</year>; <volume>6</volume>(<issue>1</issue>):<fpage>280</fpage>–<lpage>286</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3892/ol.2013.1353" xlink:type="simple">10.3892/ol.2013.1353</ext-link></comment> <object-id pub-id-type="pmid">23946818</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fackler</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Malone</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Schilling</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Garrett-Mayer</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Swift-Scanlan</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid</article-title>. <source>Clin Cancer Res</source>. <year>2006</year>; <volume>12</volume>(<issue>11</issue> Pt 1):<fpage>3306</fpage>–<lpage>3310</lpage>.</mixed-citation></ref>
<ref id="pone.0173194.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Arantes</surname> <given-names>LM</given-names></name>, <name name-style="western"><surname>de Carvalho</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Melendez</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Centrone</surname> <given-names>CC</given-names></name>, <name name-style="western"><surname>Gois-Filho</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Toporcov</surname> <given-names>TN</given-names></name>, <etal>et al</etal>. <article-title>Validation of methylation markers for diagnosis of oral cavity cancer</article-title>. <source>Eur J Cancer</source>. <year>2015</year>; <volume>51</volume>(<issue>5</issue>):<fpage>632</fpage>–<lpage>641</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ejca.2015.01.060" xlink:type="simple">10.1016/j.ejca.2015.01.060</ext-link></comment> <object-id pub-id-type="pmid">25686481</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Choudhury</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Ghosh</surname> <given-names>SK</given-names></name>. <article-title>Promoter Hypermethylation Profiling Identifies Subtypes of Head and Neck Cancer with Distinct Viral, Environmental, Genetic and Survival Characteristics</article-title>. <source>PLoS One</source>. <year>2015</year>; <volume>10</volume>(<issue>6</issue>):<fpage>e0129808</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0129808" xlink:type="simple">10.1371/journal.pone.0129808</ext-link></comment> <object-id pub-id-type="pmid">26098903</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rettori</surname> <given-names>MM</given-names></name>, <name name-style="western"><surname>de Carvalho</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Longo</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>de Oliveira</surname> <given-names>CZ</given-names></name>, <name name-style="western"><surname>Kowalski</surname> <given-names>LP</given-names></name>, <name name-style="western"><surname>Carvalho</surname> <given-names>AL</given-names></name>, <etal>et al</etal>. <article-title>TIMP3 and CCNA1 hypermethylation in HNSCC is associated with an increased incidence of second primary tumors</article-title>. <source>J Transl Med</source>. <year>2013</year>; <volume>11</volume>:<fpage>316</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1479-5876-11-316" xlink:type="simple">10.1186/1479-5876-11-316</ext-link></comment> <object-id pub-id-type="pmid">24359512</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>ZT</given-names></name>, <name name-style="western"><surname>He</surname> <given-names>QB</given-names></name>, <name name-style="western"><surname>Jiang</surname> <given-names>WW</given-names></name>. <article-title>DAPK promoter hypermethylation in tissues and body fluids of oral precancer patients</article-title>. <source>Med Oncol</source>. <year>2012</year>; <volume>29</volume>(<issue>2</issue>):<fpage>729</fpage>–<lpage>733</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s12032-011-9953-5" xlink:type="simple">10.1007/s12032-011-9953-5</ext-link></comment> <object-id pub-id-type="pmid">21516484</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Paluszczak</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Misiak</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Wierzbicka</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Wozniak</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Baer-Dubowska</surname> <given-names>W</given-names></name>. <article-title>Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa</article-title>. <source>Oral Oncol</source>. <year>2011</year>; <volume>47</volume>(<issue>2</issue>):<fpage>104</fpage>–<lpage>107</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.oraloncology.2010.11.006" xlink:type="simple">10.1016/j.oraloncology.2010.11.006</ext-link></comment> <object-id pub-id-type="pmid">21147548</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wong</surname> <given-names>Y-K</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>L-T</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>C-J</given-names></name>. <article-title>Hypermethylation of MGMT and DAPK gene promoters is associated with tumorigenesis and metastasis in oral squamous cell carcinoma</article-title>. <source>Journal of Dental Sciences</source>. <year>2011</year>; <volume>6</volume>(<issue>3</issue>):<fpage>158</fpage>–<lpage>164</lpage>.</mixed-citation></ref>
<ref id="pone.0173194.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Laytragoon-Lewin</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Castro</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Elmberger</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Rutqvist</surname> <given-names>LE</given-names></name>, <name name-style="western"><surname>Lewin</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>DNA content and methylation of p16, DAPK and RASSF1A gene in tumour and distant, normal mucosal tissue of head and neck squamous cell carcinoma patients</article-title>. <source>Anticancer Res</source>. <year>2010</year>; <volume>30</volume>(<issue>11</issue>):<fpage>4643</fpage>–<lpage>4648</lpage>. <object-id pub-id-type="pmid">21115918</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Su</surname> <given-names>PF</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>WL</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>HT</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>CH</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>TY</given-names></name>, <name name-style="western"><surname>Kao</surname> <given-names>SY</given-names></name>. <article-title>p16(INK4A) promoter hypermethylation is associated with invasiveness and prognosis of oral squamous cell carcinoma in an age-dependent manner</article-title>. <source>Oral Oncol</source>. <year>2010</year>; <volume>46</volume>(<issue>10</issue>):<fpage>734</fpage>–<lpage>739</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.oraloncology.2010.07.002" xlink:type="simple">10.1016/j.oraloncology.2010.07.002</ext-link></comment> <object-id pub-id-type="pmid">20729138</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Steinmann</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Sandner</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Schagdarsurengin</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Dammann</surname> <given-names>RH</given-names></name>. <article-title>Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma</article-title>. <source>Oncol Rep</source>. <year>2009</year>; <volume>22</volume>(<issue>6</issue>):<fpage>1519</fpage>–<lpage>1526</lpage>. <object-id pub-id-type="pmid">19885608</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>De Schutter</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Geeraerts</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Verbeken</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Nuyts</surname> <given-names>S</given-names></name>. <article-title>Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only</article-title>. <source>Oncol Rep</source>. <year>2009</year>; <volume>21</volume>(<issue>2</issue>):<fpage>507</fpage>–<lpage>513</lpage>. <object-id pub-id-type="pmid">19148529</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Righini</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>de Fraipont</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Timsit</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Faure</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Brambilla</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Reyt</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence</article-title>. <source>Clin Cancer Res</source>. <year>2007</year>; <volume>13</volume>(<issue>4</issue>):<fpage>1179</fpage>–<lpage>1185</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1158/1078-0432.CCR-06-2027" xlink:type="simple">10.1158/1078-0432.CCR-06-2027</ext-link></comment> <object-id pub-id-type="pmid">17317827</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kong</surname> <given-names>WJ</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Guo</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>D</given-names></name>. <article-title>Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer</article-title>. <source>Laryngoscope</source>. <year>2005</year>; <volume>115</volume>(<issue>8</issue>):<fpage>1395</fpage>–<lpage>1401</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/01.MLG.0000166708.23673.3A" xlink:type="simple">10.1097/01.MLG.0000166708.23673.3A</ext-link></comment> <object-id pub-id-type="pmid">16094112</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kulkarni</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Saranath</surname> <given-names>D</given-names></name>. <article-title>Concurrent hypermethylation of multiple regulatory genes in chewing tobacco associated oral squamous cell carcinomas and adjacent normal tissues</article-title>. <source>Oral Oncol</source>. <year>2004</year>; <volume>40</volume>(<issue>2</issue>):<fpage>145</fpage>–<lpage>153</lpage>. <object-id pub-id-type="pmid">14693237</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Misawa</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Mochizuki</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Imai</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Endo</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Mima</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Misawa</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer</article-title>. <source>Oncotarget</source>. <year>2016</year>.</mixed-citation></ref>
<ref id="pone.0173194.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pierini</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Jordanov</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Mitkova</surname> <given-names>AV</given-names></name>, <name name-style="western"><surname>Chalakov</surname> <given-names>IJ</given-names></name>, <name name-style="western"><surname>Melnicharov</surname> <given-names>MB</given-names></name>, <name name-style="western"><surname>Kunev</surname> <given-names>KV</given-names></name>, <etal>et al</etal>. <article-title>Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients</article-title>. <source>Head Neck</source>. <year>2014</year>; <volume>36</volume>(<issue>8</issue>):<fpage>1103</fpage>–<lpage>1108</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/hed.23413" xlink:type="simple">10.1002/hed.23413</ext-link></comment> <object-id pub-id-type="pmid">23804521</object-id></mixed-citation></ref>
<ref id="pone.0173194.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Supic</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Kozomara</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Brankovic-Magic</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Jovic</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Magic</surname> <given-names>Z</given-names></name>. <article-title>Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients</article-title>. <source>Oral Oncol</source>. <year>2009</year>; <volume>45</volume>(<issue>12</issue>):<fpage>1051</fpage>–<lpage>1057</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.oraloncology.2009.07.007" xlink:type="simple">10.1016/j.oraloncology.2009.07.007</ext-link></comment> <object-id pub-id-type="pmid">19665921</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>